Financials

  • Market Capitalization 1.98 B
  • Employee 59
  • Founded 2019
  • CEO N/A
  • Website www.sionnatx.com
  • Headquarter Delaware, United States
  • FIGI BBG016X2DC85
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-21.88
Rapporto prezzo/fatturato
4 110.11

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1989
ABCL
AbCellera Biologics Inc. - Common Shares
6.52 USD-4.12%-21.63%+19.20%+47.85%1.99 B USD
1990
SRPT
Sarepta Therapeutics, Inc. - Common Stock
18.82 USD-0.69%-2.34%+20.03%-3.59%1.99 B USD
2000
VRDN
Viridian Therapeutics, Inc. - Common Stock
18.99 USD-3.80%-1.20%+14.54%-15.41%1.96 B USD
2008
TYRA
Tyra Biosciences, Inc. - Common Stock
32.67 USD-0.24%+5.18%+20.15%+127.82%1.94 B USD